All Stories

  1. Brain connectivity as a new target for Alzheimer’s disease therapy?
  2. Brain Connectivity Gradients Alterations in Discordant Cerebrospinal Fluid Profile for Alzheimer's Disease Biomarkers
  3. Medical risk factors, ApoE haplotype, and Alzheimer’s disease: a large-scale analysis
  4. Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task
  5. Linking Personality Traits to Disability Progression in Multiple Sclerosis: A Longitudinal Analysis
  6. Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities
  7. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland
  8. Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis
  9. Association of Motoric Cognitive Risk Syndrome and High C-Reactive Protein Serum Levels With Incident Major Neurocognitive Disorder: Results From the Quebec NuAge Cohort
  10. Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?
  11. Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression
  12. Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum
  13. Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
  14. Normal pressure hydrocephalus and cognitive impairment: The gait phenotype matters too
  15. Markers of limbic system damage following SARS-CoV-2 infection
  16. Impact of Subjective Evaluations in Predicting Response to Ventriculoperitoneal Shunt for Idiopathic Normal Pressure Hydrocephalus
  17. Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection
  18. Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?
  19. Gait stability in ambulant children with cerebral palsy during dual tasks
  20. The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19
  21. “Emergency Room Evaluation and Recommendations” and Incident Hospital Admissions in Older People with Major Neurocognitive Disorders Visiting Emergency Department: Results of an Experimental Study
  22. Decrease in pain perception during acute SARS-CoV-2 infection: a case series
  23. COVID-19 associated stroke and cerebral endotheliitis
  24. COVID‐19 encephalopathy: Clinical and neurobiological features
  25. Beyond silent hypoxemia: Does COVID‐19 can blunt pain perception? Comment on “The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients”
  26. Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters
  27. Dyspnea: The vanished warning symptom of COVID‐19 pneumonia
  28. Smoothness of Gait in Healthy and Cognitively Impaired Individuals: A Study on Italian Elderly Using Wearable Inertial Sensor
  29. Commentary: Prevalence of Alternative Diagnoses and Implications for Management in Idiopathic Normal Pressure Hydrocephalus Patients
  30. Motoric cognitive risk syndrome and incident dementia: results from a population‐based prospective and observational cohort study
  31. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation
  32. Deconstructing or reestablishing frontal gait in normal pressure hydrocephalus?
  33. Is frontal gait a myth in normal pressure hydrocephalus?
  34. Motoric cognitive risk syndrome and mortality: results from the EPIDOS cohort
  35. The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients
  36. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics
  37. Brain comorbidities in normal pressure hydrocephalus
  38. Neural correlates of gait variability in people with multiple sclerosis with fall history
  39. Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders
  40. Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental "Gait, cOgnitiOn & Decline" Initiative
  41. Brain comorbidities in normal pressure hydrocephalus
  42. Apathy in idiopathic normal pressure hydrocephalus: A marker of reversible gait disorders
  43. Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis
  44. Does fear of falling predict gait variability in multiple sclerosis?
  45. CSF tapping also improves mental imagery of gait in normal pressure hydrocephalus
  46. Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment?
  47. Erratum
  48. The influence of individual motor imagery ability on cerebral recruitment during gait imagery
  49. Contribution of Brain Imaging to the Understanding Of Gait Disorders in Alzheimer’s Disease
  50. Derivation and validation of a Short Form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint
  51. Gait and motor imagery of gait in early schizophrenia
  52. Effects of amygdala–hippocampal stimulation on interictal epileptic discharges
  53. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association
  54. Adapted Timed Up and Go: A Rapid Clinical Test to Assess Gait and Cognition in Multiple Sclerosis
  55. Gait control: a specific subdomain of executive function?
  56. Does Memantine Improve the Gait of Individuals with Alzheimer's Disease?
  57. Development of a short form of Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint: a case control study
  58. Association Between High Variability of Gait Speed and Mild Cognitive Impairment: A Cross-Sectional Pilot Study
  59. Timed up and go test and risk of falls in older adults: A systematic review
  60. Biology of gait control: Vitamin D involvement
  61. Test-retest reliability of stride time variability while dual tasking in healthy and demented adults with frontotemporal degeneration
  62. Poor creativity in frontotemporal dementia: A window into the neural bases of the creative mind
  63. Interest of dual-task-related gait changes in idiopathic normal pressure hydrocephalus
  64. Decrease in gait variability while counting backward: a marker of “magnet effect”?
  65. Imagined Timed Up & Go test: A new tool to assess higher-level gait and balance disorders in older adults?
  66. EFFECT OF PSYCHOACTIVE MEDICATION ON GAIT VARIABILITY IN COMMUNITY-DWELLING OLDER ADULTS: A CROSS-SECTIONAL STUDY
  67. Antiepileptic drugs modify power of high EEG frequencies and their neural generators
  68. Frontotemporal dementia: Pathology of gait?
  69. Vitamin D and cognitive performance in adults: a systematic review
  70. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study
  71. Stops walking when talking: a predictor of falls in older adults?
  72. Gait Variability among Healthy Adults: Low and High Stride-to-Stride Variability Are Both a Reflection of Gait Stability
  73. Walking speed-related changes in stride time variability: effects of decreased speed
  74. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia
  75. Recurrent Falls and Dual Task–Related Decrease in Walking Speed: Is There a Relationship?
  76. GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE
  77. Concurrent validity of SMTEC® footswitches system for the measurement of temporal gait parameters
  78. Does Change in Gait while Counting Backward Predict the Occurrence of a First Fall in Older Adults?
  79. Dual Task–Related Changes in Gait Performance in Older Adults: A New Way of Predicting Recurrent Falls?
  80. Impact of Impaired Executive Function on Gait Stability
  81. Changes in gait while backward counting in demented older adults with frontal lobe dysfunction
  82. Mild clinical expression of Lambert Eaton myasthenic syndrome in a patient with HIV infection
  83. 'Faster counting while walking' as a predictor of falls in older adults
  84. Is low lower-limb kinematic variability always an index of stability?
  85. Myasthenia gravis associated with HTLV-I infection and atypical brain lesions
  86. LONG-TERM PRACTICE OF JAQUES-DALCROZE EURHYTHMICS PREVENTS AGE-RELATED INCREASE OF GAIT VARIABILITY UNDER A DUAL TASK